CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common stock	Treasury Stock	Additional paid-in capital	Accumulated Other Comprehensive Loss	Accumulated deficit
Common stock, beginning balance (in shares) at Dec. 31, 2022		21,068,697
Beginning balance at Dec. 31, 2022	$ 278,401	$ 1	$ 0	$ 1,153,071	$ (1,563)	$ (873,108)
Treasury stock, beginning balance (in shares) at Dec. 31, 2022			0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon release of restricted stock units (in shares)		232,993
Shares withheld related to net share settlement (in shares)		2,285
Shares withheld related to net share settlement	(44)			(44)
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)		95,892
Issuance of common stock upon release of restricted stock units	89			89
Stock repurchased by the company and held as treasury stock (in shares)		(2,314,908)	2,314,908
Stock repurchased by the Company and held as treasury stock	(13,000)		$ (13,000)
Stock issued under employee stock purchase plan (in shares)		98,087
Stock issued under employee stock purchase plan	1,155			1,155
Stock-based compensation	43,692			43,692
Other comprehensive income	1,556				1,556
Net loss	(101,360)					(101,360)
Common stock, ending balance (in shares) at Dec. 31, 2023		19,183,046
Ending balance at Dec. 31, 2023	$ 210,489	$ 1	$ (13,000)	1,197,963	(7)	(974,468)
Treasury stock, ending balance (in shares) at Dec. 31, 2023	2,300,000		2,314,908
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon release of restricted stock units (in shares)		420,747
Shares withheld related to net share settlement (in shares)		227,112
Shares withheld related to net share settlement	$ (1,438)			(1,438)
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)	1,787	1,801
Issuance of common stock upon release of restricted stock units	$ 2			2
Stock repurchased by the company and held as treasury stock (in shares)		(3,101,510)	3,101,510
Stock repurchased by the Company and held as treasury stock	(19,349)		$ (19,349)
Stock issued under employee stock purchase plan (in shares)		5,708
Stock issued under employee stock purchase plan	28			28
Stock-based compensation	30,087			30,087
Other comprehensive income	7				7
Net loss	(46,790)					(46,790)
Common stock, ending balance (in shares) at Dec. 31, 2024		16,736,904
Ending balance at Dec. 31, 2024	$ 173,036	$ 1	$ (32,349)	$ 1,226,642	$ 0	$ (1,021,258)
Treasury stock, ending balance (in shares) at Dec. 31, 2024	5,400,000		5,416,418